AOD-9604 / MOTs-C

AOD 9604 is a modified version of the hGH fragment 176-191 peptide, distinguished by the presence of a di-sulfide bridge. Originally designed as a lipolytic (fat burning) compound, AOD 9604 has exhibited promising outcomes in various areas of medical research. Studies have explored its potential benefits in addressing conditions such as heart disease, osteoarthritis with a focus on cartilage repair, and metabolic syndrome. Notably, AOD 9604 has demonstrated its ability to stimulate lipolysis, the process of breaking down or destroying fat, while concurrently inhibiting lipogenesis in animal models.

MOTS-c, short for Mitochondrial-Derived Peptide MOTS-c, emerges as a pivotal player in promoting metabolic balance, extending longevity, enhancing performance capacity, and combating various health conditions. Encoded within the mitochondrial genome, MOTS-c belongs to the broader family of mitochondrial-derived peptides (MDPs), which have recently gained recognition as bioactive hormones crucial for mitochondrial communication and energy regulation.